Latest filing published 16 May 2019 for FIVE PRIME THERAPEUTICS INC, €5,073.
Insider track record
Bryan Irving: trading record in brief
All filings by Bryan Irving on record concern Five Prime Therapeutics Inc. We count 8 filings; the first trade dates from 1 September 2017 and the latest from 15 May 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 16 May 2019, the filings show a share grant worth €5,073 in Five Prime Therapeutics Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bryan Irving
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 620 shares@ US$9.1710.9% of flowCommon StockSEC:0001209191-19-030602:0
- 3,750 shares0Common StockSEC:0001209191-19-023661:0
- 10,000 shares0Common StockSEC:0001209191-19-014263:0
- 1,118 shares@ US$11.9525.2% of flowCommon StockSEC:0001209191-19-014263:1
- 2,479 shares@ US$14.0063.9% of flowCommon StockSEC:0001209191-18-049429:0
- 3,750 shares0Common StockSEC:0001209191-18-030087:0
- 6,000 shares0Common StockSEC:0001209191-18-014715:0
- 15,000 shares0Common StockSEC:0001209191-17-051260:0
8 of 8 declarations
